Explore the Global Schizophrenia Treatment Market— analysis of key trends, regional growth, top players, and a 10-year forecast from 2026 to 2036.

Future Market Insights

Schizophrenia Treatment Market

Key Insight

Demand for schizophrenia treatment will increase through 2036, with atypical antipsychotic drugs at 51.2% of the product type segment in 2026, driven by high adoption across primary application categories. The market was valued at USD 11.20 billion in 2025 and is expected to be worth USD 24.56 billion by 2036.

May 18, 2026

Anurag Sharma

250 Pages

Cite this Report

Schizophrenia Treatment Market

https://www.futuremarketinsights.com/reports/schizophrenia-treatment-market

License

Buy Now

Summary ToC Infographics Companies

Key Players

Acadia Pharmaceuticals Inc
Boehringer Ingelheim
Bristol-Myers Squibb
Karuna Therapeutics
Minerva Neurosciences
Mitsubishi Tanabe Pharma Corporation
Otsuka Pharmaceuticals Co. Ltd
Reviva Pharmaceuticals
Rovi Pharmaceuticals Laboratories
Royalty Pharma
Sumitomo Pharma Co. Ltd

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Schizophrenia Treatment Market

Key Players

Similar Industry Reports